Established in 2003 by Dr. M. Akram Khan, NDRA has grown steadily for more than 10 years building our expertise in clinical research operations to become one of the leading clinical research companies. We are a team of professional and dedicated staff led by Dr. Khan, who manages and conducts a vast variety of clinical trials.
At NDRA, we don’t make a commitment until we are absolutely sure to deliver the results. We have a reputation of accepting difficult protocols and fulfilling our promise by providing highly compliant data with maximum enrollments. On multiple occasions, NDRA has been ranked amongst top enrollers, ahead of many other nationally recognized clinical research facilities. Our subject retention rate is close to 100% on all our clinical trials.
Currently, the site has three principal investigators conducting clinical trials under various specialties.
Our cardiovascular trials are being performed under guidance of Dr. Khan. Major cardiovascular related research includes conditions:
|– Hypertension||– Pacemaker|
|– Hyperlipidemia||– ICDs|
|– A-FIB||– Coronary & Peripheral Stents|
|– Acute Coronary Syndrome||– Obesity|
|– Diabetes||– Coronary Artery Disease|
|– Peripheral Artery Disease||– Heart Failure|
|– Pacemaker||– ICDs|
|– Coronary; Peripheral Stents||– Obesity|
|– Chronic Angina||– Carotid; Peripheral Artery Disease|
Dr. Ashfaque is responsible to conduct wide range of clinical trials including:
|– Pulmonology||– Sleep Disorders|
|– Urology||– Infectious Disease|
|– Nephrology||– Allergies / vaccines|
|– Neurology||– Genomics|
|– Behavioral Medicine||– Obesity|
|– Gastroenterology||– Psychiatry|
While, team for neurovascular trials is led by Dr. Khalid who is specialized in Stroke, Alzheimer’s, Multiple Sclerosis, Parkinsonism and other neurological disorders.
|– Stroke / TIA||– Alzheimer’s Disease|
|– Multiple Sclerosis||– Parkinsonism|
|– Migraine||– Epilepsy|